These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 6134583)

  • 1. Glucocorticoid-resistant human acute lymphoblastic leukemic cell line with functional receptor.
    Zawydiwski R; Harmon JM; Thompson EB
    Cancer Res; 1983 Aug; 43(8):3865-73. PubMed ID: 6134583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
    Schmidt TJ
    Cancer Res; 1989 Aug; 49(16):4390-5. PubMed ID: 2743328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor properties and glucocorticoid regulation of glutamine synthetase activity in sensitive C6 and resistant C6H glial cells.
    Holbrook NJ; Grasso RJ; Hackney JF
    J Neurosci Res; 1981; 6(1):75-88. PubMed ID: 6111614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798.
    Stevens J; Stevens YW
    Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of glucocorticoid-resistant human leukemic cells by somatic cell hybridization.
    Harmon JM; Thompson EB; Baione KA
    Cancer Res; 1985 Apr; 45(4):1587-93. PubMed ID: 2858265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
    Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
    Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine synthetase induction by glucocorticoids in the glucocorticoid-sensitive human leukemic cell line CEM-C7.
    Harmon JM; Thompson EB
    J Cell Physiol; 1982 Feb; 110(2):155-60. PubMed ID: 6121820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple forms and fragments of cytosolic glucocorticoid receptors from human leukemic cells and normal lymphocytes.
    Sherman MR; Stevens YW; Tuazon FB
    Cancer Res; 1984 Sep; 44(9):3783-96. PubMed ID: 6589045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of activated and nonactivated cytoplasmic glucocorticoid-receptor complexes from human leukemia cells by rapid DNA-diethylaminoethyl minicolumn chromatography.
    Holbrook NJ; Bloomfield CD; Munck A
    Cancer Res; 1983 Sep; 43(9):4478-82. PubMed ID: 6871878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of [3H]cortivazol to characterize glucocorticoid receptors in a dexamethasone-resistant human leukemic cell line.
    Schlechte JA; Schmidt TJ
    J Clin Endocrinol Metab; 1987 Mar; 64(3):441-6. PubMed ID: 2880860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of glucocorticoid-specific binding in the L2C leukemia.
    Ruh MF; Germain CJ; Nadel EM; Ruh TS
    Cancer Res; 1981 Jan; 41(1):138-43. PubMed ID: 6934847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]cortivazol: a unique high affinity ligand for the glucocorticoid receptor.
    Schlechte JA; Simons SS; Lewis DA; Thompson EB
    Endocrinology; 1985 Oct; 117(4):1355-62. PubMed ID: 4029081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human leukemic glucocorticoid receptors using affinity labeling and anti-human glucocorticoid receptor antibodies.
    Harmon JM; Eisen HJ; Brower ST; Simons SS; Langley CL; Thompson EB
    Cancer Res; 1984 Oct; 44(10):4540-7. PubMed ID: 6331880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of labile glucocorticoid-receptor complexes from acute nonlymphocytic leukemia cells by a factor from chronic lymphocytic leukemia cells.
    Holbrook NJ; Bloomfield CD; Munck A
    Cancer Res; 1984 Jan; 44(1):407-14. PubMed ID: 6690056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activation and DNA binding affinity of human lymphoid (CEM-C7) cytoplasmic receptors labeled with the antiglucocorticoid RU 38486.
    Schmidt TJ
    J Steroid Biochem; 1986 Apr; 24(4):853-63. PubMed ID: 2871233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intracellular free Ca(II) and Zn(II) in dexamethasone-induced apoptosis and dexamethasone resistance in human leukemic CEM cell lines.
    Adebodun F; Post JF
    J Cell Physiol; 1995 Apr; 163(1):80-6. PubMed ID: 7896902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulator inhibits nuclear translocation of the glucocorticoid receptor and inhibits glucocorticoid-induced apoptosis in the human leukemic cell line CEM C-7.
    Robertson NM; Bodine PV; Hsu TC; Alnemri ES; Litwack G
    Cancer Res; 1995 Feb; 55(3):548-56. PubMed ID: 7834624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a glucocorticoid-sensitive human lymphoid cell line.
    Norman MR; Thompson EB
    Cancer Res; 1977 Oct; 37(10):3785-91. PubMed ID: 269011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementation between glucocorticoid receptor and lymphocytolysis in somatic cell hybrids of two glucocorticoid-resistant human leukemic clonal cell lines.
    Yuh YS; Thompson EB
    Somat Cell Mol Genet; 1987 Jan; 13(1):33-45. PubMed ID: 3468632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.